MAPK/ERK通路
肾损伤
医学
肾病
信号转导
药理学
肾
内分泌学
生物
生物化学
糖尿病
作者
Ziyang Lin,Zhaodi Wang,Van Pham Kim Thuong,Xianlong Zhang,Baien Liang,Minyi Li,Mengqiu Li,Tingting Duan,Zhenghai Li,Ping Li,Aihua Wu,Junzheng Yang,Kun Bao,Bo Liu
标识
DOI:10.1016/j.jep.2025.119813
摘要
SQQS ameliorates MN progression by inhibiting the MEK/ERK pathway, suppressing EMT, and reducing macrophage recruitment, with methylnissolin-3-O-glucoside as a key bioactive component.
科研通智能强力驱动
Strongly Powered by AbleSci AI